Graphic Designer II – Visual & Digital Content (Remote) (contract) jobs in United States
cer-icon
Apply on Employer Site
company-logo

Sanofi · 9 hours ago

Graphic Designer II – Visual & Digital Content (Remote) (contract)

Sanofi is seeking a Graphic Designer II for their FLEXT Direct contingent workforce program. This role focuses on creating high-quality digital content across multiple channels, translating brand strategy and clinical data into engaging visual storytelling for healthcare audiences.

Health CareLife SciencePharmaceuticalTherapeutics

Responsibilities

Create a wide variety of visual design deliverables, including HTML emails, animated banners, social assets, infographics, and charts
Work across multiple brands, including diabetes, insulin, transplant, and other therapeutic areas
Translate complex clinical data into clear, visually compelling storytelling for healthcare audiences
Collaborate closely with copywriters, marketers, and content quality partners to deliver scalable, submission-ready creative
Ensure all designs comply with regulatory standards (pharma, medical, or other regulated environments)
Utilize AI and automation tools to enhance visual design workflows and efficiency

Qualification

Graphic DesignVisual Content CreationRegulated EnvironmentsHTML DesignAI Design PlatformsMotion GraphicsAttention to DetailCollaboration Skills

Required

Minimum of 3 years professional experience in graphic design or visual content creation
Diverse experience across digital, print, animated, and HTML design
Proven experience working in regulated environments (pharma, medical devices, legal, or similar)
Strong attention to detail, creativity, and ability to work efficiently under tight deadlines
Excellent communication and collaboration skills

Preferred

Experience with multiple brands or therapeutic areas is a plus
Familiarity with AI design platforms or automation tools
Experience with motion graphics or video content

Company

Sanofi is a global biopharma company focused on prescription drugs, vaccines, and treatments for chronic, rare, and infectious diseases.

Funding

Current Stage
Public Company
Total Funding
$6.97B
Key Investors
Blackstone Life SciencesEvotec
2025-10-28Post Ipo Debt· $3B
2025-06-17Post Ipo Debt· $1.74B
2025-03-05Post Ipo Debt· $1.59B

Leadership Team

leader-logo
Paul Hudson
Chief Executive Officer
linkedin
leader-logo
Francois-Xavier Roger
Chief Financial Officer
linkedin
Company data provided by crunchbase